Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization

BACKGROUND: Hepatocellular carcinoma (HCC) patients who are at significant risk of tumor recurrence and mortality can benefit from postoperative adjuvant transarterial chemoembolization (PA-TACE). However, the benefits of PA-TACE remain unclear. Herein, we aimed to develop a model for predicting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Xinyue, Zhang, Jie, Li, Minjun, Lu, Fei, Wang, Ting, Gong, Wenfeng, Xiang, Bangde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612509/
https://www.ncbi.nlm.nih.gov/pubmed/37901717
http://dx.doi.org/10.2147/JHC.S422565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612509/
https://www.ncbi.nlm.nih.gov/pubmed/37901717
http://dx.doi.org/10.2147/JHC.S422565

Ejemplares similares